Lawrence E Ginsberg

Professor

  • 3942 Citations
  • 36 h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Lawrence E Ginsberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Neoplasms Medicine & Life Sciences
Neck Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Head Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
X Ray Computed Tomography Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Facial Nerve
Magnetic Resonance Imaging
Sensitivity and Specificity
Mastoid
Head and Neck Neoplasms

Styloid Process Osteoradionecrosis: Report of 3 Cases

Elakkad, A., Romero-Sanchez, G. T., Forghani, R. & Ginsberg, L. E., May 1 2019, In : Journal of computer assisted tomography. 43, 3, p. 472-474 3 p.

Research output: Contribution to journalArticle

Osteoradionecrosis
Neck
Radiotherapy
Head
Neoplasms
2 Citations (Scopus)

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Haddad, R. I., Massarelli, E., Lee, J. J., Lin, H. Y., Hutcheson, K., Lewis, J., Garden, A. S., Blumenschein, G. R., William, W. N., Pharaon, R. R., Tishler, R. B., Glisson, B. S., Pickering, C., Gold, K. A., Johnson, F. M., Rabinowits, G., Ginsberg, L. E., Williams, M. D., Myers, J., Kies, M. S. & 1 others, Papadimitrakopoulou, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 471-477 7 p.

Research output: Contribution to journalArticle

docetaxel
Carboplatin
Paclitaxel
Fluorouracil
Cisplatin
Adenoid Cystic Carcinoma
Adjuvant Radiotherapy
Radiosurgery
Skull Base
Conformal Radiotherapy
2 Citations (Scopus)

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

William Jr, W. N., Tsao, A., Feng, L., Ginsberg, L. E., Lee, J-K. J., Kies, M. S., Glisson, B. S. & Kim, E. S., May 1 2018, In : Oncologist. 23, 5, p. 526-e49

Research output: Contribution to journalArticle

docetaxel
Cisplatin
Maintenance
Oropharyngeal Neoplasms
Combined Modality Therapy